National Heart, Lung, and Blood Institute; Notice of Closed Meeting, 58919 [2021-23192]
Download as PDF
<![CDATA[
58919
Federal Register / Vol. 86, No. 203 / Monday, October 25, 2021 / Notices
Date: November 22, 2021.
Time: 10:00 a.m. to 4:00 p.m. Eastern Time
(ET).
Agenda: The meeting will cover committee
business items including updates on pain
workforce enhancement and pain research
concepts. It will include follow up of IPRCC
recommendations and member updates.
Webcast Live: https://videocast.nih.gov/.
Deadline: Submission of intent to submit
written/electronic statement for comments:
Monday, November 15th, by 5:00 p.m. ET.
Place: National Institutes of Health,
Building 31, 31 Center Drive Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Linda L. Porter, Ph.D.,
Director, Office of Pain Policy and Planning,
Office of the Director, National Institute of
Neurological Disorders and Stroke, NIH, 31
Center Drive, Room 8A31, Bethesda, MD
20892, Phone: (301) 451–4460, Email:
Linda.Porter@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
The meeting will be open to the public via
NIH Videocast https://videocast.nih.gov/.
Visit the IPRCC website for more
information: https://iprcc.nih.gov. Agenda and
any additional information for the meeting
will be posted when available.
Dated: October 19, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Heart, Lung, and
Blood Initial Review Group; NHLBI
Institutional Training Mechanism Study
Section.
Date: December 10, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Health, 6705
Rockledge Drive, Bethesda, MD 20817
(Virtual Meeting).
Contact Person: Lindsay M. Garvin, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Room 208–Y,
Bethesda, MD 20892, (301) 827–7911,
lindsay.garvin@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: October 19, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–23192 Filed 10–22–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2021–23191 Filed 10–22–21; 8:45 am]
BILLING CODE 4140–01–P
Substance Abuse and Mental Health
Services Administration
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
National Institutes of Health
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer at (240) 276–0361.
jspears on DSK121TN23PROD with NOTICES1
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
Project: Minority AIDS InitiativeManagement Reporting Tools (MAI–
MRTs)—(OMB No. 0930–0357)—
Revision
The Substance Abuse and Mental
Health Services Administration
(SAMHSA), Center for Substance Abuse
Prevention (CSAP) is requesting from
the Office of Management and Budget
(OMB) approval for the revised Minority
AIDS Initiative (MAI) monitoring tools,
which includes both youth and adult
questionnaires as well as the quarterly
progress report. This renewal includes
the inclusion of new cohorts.
The cohorts of grantees funded by the
MAI and included in this clearance
request are:
• Capacity Building Initiative 2017
• Capacity Building Initiative 2018
• Prevention Navigators 2017
• Prevention Navigators 2019
• Prevention Navigators 2020
• Prevention Navigators 2021
The target population for the MAI
grantees will be at-risk minority
adolescents and young adults. All MAI
grantees are expected to report their
monitoring data using SAMHSA’s
Strategic Prevention Framework (SPF)
to target minority populations, as well
as other high-risk groups residing in
communities of color with high
prevalence of Substance Abuse and
HIV/AIDS. The primary objectives of the
monitoring tools include:
• Assess the success of the MAI in
reducing risk factors and increasing
protective factorsassociated with the
transmission of the Human
Immunodeficiency Virus (HIV),
Hepatitis C Virus (HCV), and other
sexually transmitted diseases (STD).
• Measure the effectiveness of
evidence-based programs and
infrastructure development activities
such as: Outreach and training,
mobilization of key stakeholders,
substance abuse and HIV/AIDS
counseling and education, testing,
referrals to appropriate medical
treatment and/or other intervention
strategies (i.e., cultural enrichment
activities, educational and vocational
resources, social marketing campaigns,
and computer-based curricula).
• Investigate intervention types and
features that yield the best outcomes for
specific population groups.
• Assess the extent to which access to
health care was enhanced for
population groups and individuals
vulnerable to behavioral health
disparities residing in communities
targeted by funded interventions.
• Assess the process of adopting and
implementing the SPF with the target
populations.
TABLE 1—ESTIMATES OF ANNUALIZED HOUR BURDEN
Number of
respondents
Type of respondent activity
Quarterly Progress Report .................................................
VerDate Sep<11>2014
18:00 Oct 22, 2021
Jkt 256001
PO 00000
Frm 00061
Responses per
respondent
197
Fmt 4703
Sfmt 4703
Total
responses
4
E:\FR\FM\25OCN1.SGM
732
25OCN1
Hours per
response
Total burden
hours
4
2,928
]]>Agencies
[Federal Register Volume 86, Number 203 (Monday, October 25, 2021)]
[Notices]
[Page 58919]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-23192]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Heart, Lung, and Blood Initial Review Group;
NHLBI Institutional Training Mechanism Study Section.
Date: December 10, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Health, 6705 Rockledge Drive,
Bethesda, MD 20817 (Virtual Meeting).
Contact Person: Lindsay M. Garvin, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Room 208-Y, Bethesda, MD 20892, (301) 827-7911,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: October 19, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-23192 Filed 10-22-21; 8:45 am]
BILLING CODE 4140-01-P
